Anaesthetic having epileptogenic potential is:
The correct answer is likely to be ketamine. I remember that ketamine is an NMDA receptor antagonist, and it can lower the seizure threshold. Patients with a history of seizures are often cautioned against its use. Then there's etomidate, which is another anesthetic that can cause EEG changes resembling seizures, but I think its epileptogenic potential is less well-known compared to ketamine.
Looking at the options, if one of them is ketamine, that's the right choice. The other options might be drugs like propofol, which is actually used to treat seizures, or sevoflurane, which is a volatile anesthetic with a lower seizure threshold but not as epileptogenic as ketamine. Bupivacaine is a local anesthetic, and while it can cause seizures in overdose, the question is about anesthetic agents in general.
Wait, maybe I should double-check. Thiopental is a barbiturate that lowers the seizure threshold. But I think ketamine's effect is more direct. The key is whether the anesthetic is known to lower the seizure threshold. So the core concept is about how different anesthetics modulate neurotransmitters and receptors, affecting seizure activity.
So the correct answer is ketamine. The other options like propofol are anticonvulsants, so they're not the right choice. Etomidate might cause EEG changes but isn't as epileptogenic. So the explanation should highlight ketamine's mechanism through NMDA antagonism and its clinical implications.
**Core Concept**
This question tests knowledge of anesthetic agents that lower the seizure threshold (epileptogenic potential). Anesthetics like ketamine and etomidate may paradoxically increase seizure risk by modulating GABAergic and glutamatergic neurotransmission, while others (e.g., propofol) are anticonvulsants.
**Why the Correct Answer is Right**
**Ketamine** is an NMDA receptor antagonist with potent analgesic and dissociative properties. It lowers the seizure threshold by disinhibiting excitatory glutamatergic pathways, increasing neuronal hyperexcitability. This effect is well-documented in patients with preexisting epilepsy or structural brain lesions, where ketamine may precipitate seizures despite its GABAergic agonist activity.
**Why Each Wrong Option is Incorrect**
**Option A:** *Propofol* is a GABA-A agonist with anticonvulsant properties, used to treat refractory status epilepticus.
**Option B:** *Etomidate* may induce EEG patterns resembling seizures (electrographic seizures) but has minimal clinical epileptogenic potential.
**Option C:** *Sevoflurane* is a volatile anesthetic with a low seizure threshold but does not inherently cause seizures at standard anesthetic concentrations.
**Option D:** *Bupivacaine* toxicity (e.g., local anesthetic systemic toxicity) can cause seizures, but it is not an anesthetic agent used for general anesthesia.
**Clinical Pearl / High-Yield Fact**
Ket